REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVela Technologies Regulatory News (VELA)

Share Price Information for Vela Technologies (VELA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0125
Bid: 0.012
Ask: 0.013
Change: 0.00 (0.00%)
Spread: 0.001 (8.333%)
Open: 0.0125
High: 0.0125
Low: 0.0125
Prev. Close: 0.0125
VELA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of a 28.8% interest in Igraine plc

30 Mar 2022 13:15

RNS Number : 6299G
Vela Technologies PLC
30 March 2022
 

30 March 2022

Vela Technologies plc

("Vela" or "the Company")

Acquisition of a 28.8% interest in Igraine plc

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to announce the acquisition of 23,928,080 ordinary shares, representing 28.82% of the issued share capital, in Igraine plc ("Igraine"), the Aquis-listed med-tech investment company (https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=KING) ("the Acquisition" or "Investment").

Highlights

· Vela becomes the largest single shareholder in Igraine

· 28.82% stake acquired on 30 March 2022 for cash consideration of £430,705 at 1.8p per Igraine share

· The Investment is part of Vela's growing commitment to be more active in identifying opportunities for 'fast-track' returns for Vela shareholders from the Company's investment portfolio

Rationale for the Investment

Vela's investing policy includes investing in companies and special situations which have discernible potential to deliver returns for shareholders. Against a background of difficult capital markets, the Vela Board recognises the need to be more active in developing and delivering the means to achieve such returns.

With a healthy cash balance and as a co-investor alongside Vela in the AZD1656 Arcadia drug development programme, the Board of Vela believes that Igraine represents a compelling investment opportunity for the Company.

Information on Igraine

Igraine's business strategy is to source and develop break-through innovative technologies and commercially attractive discoveries in the health, med-tech and life science sectors worldwide.

Igraine's latest unaudited balance sheet at 30 June 2021 shows net liabilities of £58,000 and an unaudited loss before tax for the period ended 30 June 2021 of £133,000. At a general meeting held on 28 June 2021, Igraine shareholders agreed to the issue of subscription shares for gross proceeds of £2.0 million and a 2% investment in Excalibur Medicines Ltd ("EML"), a subsidiary of Excalibur Healthcare Services Ltd ("Excalibur").

EML has secured exclusive rights to and owns the patents on a drug, AZD1656, which is being developed as a therapeutic treatment for diabetics suffering from COVID-19 and other respiratory diseases. Simultaneously with its investment in EML, Igraine additionally acquired a right to co-invest in all healthcare and life-science investment opportunities sourced or invested in by Excalibur. Excalibur was founded and is wholly owned by Professor Sir Christopher Evans OBE, a renowned bio-tech entrepreneur.

Based on publicly available information, Vela has calculated that the net asset value per share of Igraine today exceeds the price that it has paid for the shares that it has acquired; and the Board of Vela is therefore of the view that Igraine's current quoted market price is not a true reflection of the underlying value of the business.

Brent Fitzpatrick, Non-Executive Chairman of Vela, holds 372,499 ordinary shares in Igraine, representing 0.449% of the current issued share capital of Igraine.

Details of the Acquisition

Vela has today acquired 23,928,080 ordinary shares in Igraine at a price of 1.8p per share from a number of existing investors in Igraine for £430,705, paid in cash from the Company's existing cash resources.

Following the Investment, Vela now has a portfolio of 12 investments.

For further information, please contact:

Vela Technologies plc

 

Brent Fitzpatrick, Non-Executive Chairman

James Normand, Executive Director

Tel: +44 (0) 7421 728875

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3328 5656

Nick Athanas/Piers Shimwell

 

Peterhouse Capital Limited (Joint Broker)

Tel: +44 (0) 20 7469 0930

Lucy Williams / Duncan Vasey / Eran Zucker 

 

 

About Vela Technologies 

Vela Technologies plc (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments. Vela's investee companies have either developed ways of utilising technology or are developing technology with a view to disrupting the businesses or sector in which they operate. Vela Technologies will also invest in already-listed companies where valuations offer additional opportunities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSDEFESEESEFD
Date   Source Headline
7th May 201912:00 pmRNSHolding(s) in Company
1st May 201911:30 amRNSFurther re. Placing
26th Apr 20191:39 pmRNSNon Regulatory: Update re. Interbit Ltd
24th Apr 20197:00 amRNSPlacing to raise £400,000 and other matters
15th Mar 20197:00 amRNSUpdate re. WeShop Limited
18th Feb 20192:45 pmRNSFurther Investment in Argo Blockchain
28th Dec 20187:00 amRNSHalf-yearly Report
17th Dec 201812:18 pmRNSUpdate re AirPortr
6th Dec 201810:07 amRNSInvestment in StreamTV Networks Inc.
30th Nov 20188:04 amRNSUpdate re. Investment in StreamTV Networks, Inc.
30th Nov 20187:00 amRNSFurther re. Convertible Unsecured Loan Notes
29th Nov 20189:55 amRNSUpdate re. BTL Group Ltd
8th Nov 201812:47 pmRNSUpdate re. BTL Group Ltd
23rd Oct 201812:24 pmRNSResult of AGM
1st Oct 20183:23 pmRNSUpdate re investment in WeShop Limited
1st Oct 20182:42 pmRNSFurther re Convertible Unsecured Loan Notes
27th Sep 20187:00 amRNSFinal Results
31st Jul 20181:47 pmRNSUpdate re. investment in Argo Blockchain plc
25th Jul 201812:00 pmRNSeasyJet partnership with AirPortr
19th Jun 20189:30 amRNSInvestment in Vibe Group Holdings Limited
12th Jun 20185:00 pmRNSHolding(s) in Company
11th Jun 201812:16 pmRNSUpdate re. investment in Argo Blockchain plc
29th May 20181:04 pmRNSUpdate re proposed investment in BlockchainK2 Corp
21st May 201811:17 amRNSUpdate re proposed investment in BlockchainK2 Corp
9th May 20187:00 amRNSUpdate re. investment in THEVIBE Ltd
9th Apr 201812:13 pmRNSNon Regulatory: Update re. BTL Group Ltd
5th Apr 20181:27 pmRNSUpdate re proposed investment in BlockchainK2 Corp
29th Mar 201810:03 amRNSFurther investment of c.£150,000 in Portr Limited
28th Mar 201812:57 pmRNSUpdate on BTL Group Ltd re Interbit
16th Mar 20181:25 pmRNSNon-regulatory: Update re BTL Group Ltd
5th Feb 20181:38 pmRNSInvestment of £200,000 in Argo Blockchain plc
22nd Jan 201810:28 amRNSUpdate re BTL Group Ltd
18th Jan 20183:37 pmRNSUpdate re proposed investment in BlockchainK2 Corp
17th Jan 201810:58 amRNSExercise of warrants in BTL Group Ltd
8th Jan 201811:39 amRNSUpdate re proposed investment in BlockchainK2 Corp
29th Dec 20171:00 pmRNSTotal Voting Rights
27th Dec 20177:00 amRNSPurchase of shares in BTL Group Ltd
21st Dec 20177:00 amRNSHalf-yearly Report
20th Dec 201710:56 amRNSFurther partial sale of holding in BTL Group Ltd
19th Dec 201711:43 amRNSPartial sale of holding in BTL Group Ltd
13th Dec 20177:00 amRNSPlacing to raise £750,000
11th Dec 201712:58 pmRNSPartial sale of holding in BTL Group Ltd
11th Dec 20177:00 amRNSUpdate on investment in Portr Limited
8th Dec 20177:00 amRNSProposed Investment
5th Dec 20171:40 pmRNSPartial sale of holding in BTL Group Ltd
29th Nov 20171:51 pmRNSPartial sale of holding in BTL Group Ltd
27th Nov 20172:32 pmRNSExercise of warrants in BTL Group Ltd
24th Nov 201712:11 pmRNSUpdate re BTL Group Ltd
23rd Nov 20172:08 pmRNSUK Bond Network Investor Evening
23rd Nov 20171:03 pmRNSFurther partial sale of holding in BTL Group Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.